These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 697137)

  • 21. Acquired c1-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities. A study of three cases.
    Hauptmann G; Lang JM; North ML; Oberling F; Mayer G; Lachmann P
    Blut; 1976 Mar; 32(3):195-206. PubMed ID: 946413
    [No Abstract]   [Full Text] [Related]  

  • 22. Haemolytic complement in peripheral lymph of normal men.
    Olszewski WL; Engeset A
    Clin Exp Immunol; 1978 Jun; 32(3):392-8. PubMed ID: 99278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Glomerular localization of the early components of complement in glomerulonephritis].
    Barbiano di Belgiojoso G; Tarantino A; Durante A; Guerra L
    Minerva Nefrol; 1974; 21(3):169-78. PubMed ID: 4463297
    [No Abstract]   [Full Text] [Related]  

  • 24. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
    Miyama A; Kato T; Horai S; Yokoo J; Kashiba S
    Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemolytic complement and its components in Syrian hamsters: a study of five strains uninfected and infected with Brugia pahangi.
    Barta O; Oyekan PP; Malone JB; Klei TR
    Adv Exp Med Biol; 1981; 134():103-10. PubMed ID: 7223531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunoenzyme determination of the C5b-9 complex of the complement system].
    Rus H; Niculescu F; Cristea A; Vlaicu R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(1):35-40. PubMed ID: 3738363
    [No Abstract]   [Full Text] [Related]  

  • 27. The complement system and nephritis.
    Müller-Eberhard HJ
    Adv Nephrol Necker Hosp; 1974; 4():3-14. PubMed ID: 4143384
    [No Abstract]   [Full Text] [Related]  

  • 28. [Complement activation and biological activities].
    Inoue K
    Nihon Saikingaku Zasshi; 1976 Jul; 31(4):535-55. PubMed ID: 988219
    [No Abstract]   [Full Text] [Related]  

  • 29. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity.
    Yamamoto KI
    J Immunol; 1977 Oct; 119(4):1482-5. PubMed ID: 894048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement-induced ultrastructural membrane lesions: requirement for terminal components.
    Packman CH; Rosenfeld SI; Weed RI; Leddy JP
    J Immunol; 1976 Nov; 117(5 Pt.2):1883-9. PubMed ID: 993584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H; Good RA; Day NK
    Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terminal complement components play a role in the expression of C5a.
    Gresham HD; Renfer L; Hammer CH; Frank MM
    J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences between plasma and serum complement in patients with chronic liver disease.
    Inai S; Kitamura H; Fujita T; Kojima J; Nagaki K
    Clin Exp Immunol; 1976 Sep; 25(3):403-9. PubMed ID: 963909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyanate as an inactivator of complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
    Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Titers of nine complement components, conglutinin and C3b-inactivator in adult and fetal bovine sera.
    Triglia RP; Linscott WD
    Mol Immunol; 1980 Jun; 17(6):741-8. PubMed ID: 7432351
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum complement profile in human leprosy and its comparison with immune complex diseases.
    Saha K; Chakraborty AK
    Int J Lepr Other Mycobact Dis; 1977; 45(4):327-37. PubMed ID: 147246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Consumption hypocomplementemia: comparative value of haemolytic and protein estimations of the components of the classical pathway (author's transl)].
    Roncato M; Vial MC; Maillet F; Peltier A
    Nouv Presse Med; 1979 May; 8(20):1657-60. PubMed ID: 112575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.